🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
Clinical study designed to collect blood for research purposes in patients ...
Status
Terminated
Location
Algemeen Ziekenhuis Delta - Campus Rumbeke
Start Date
2020-11-16
Trial ID
NCT04494061
Treatments Being Tested
RATIONALE: Studying samples of semen from cancer survivors in the laborator...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2010-02
Trial ID
NCT01077440
Treatments Being Tested
The purpose of this study is to learn how to use blood tests to better pred...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2020-02-01
Trial ID
NCT04791215
Treatments Being Tested
This study aims to evaluate the safety, feasibility, and preliminary effica...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, China
Start Date
2026-08-01
Trial ID
NCT07757685
Treatments Being Tested
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749